Dermatology offices spend ~13 hours weekly on prior authorizations, file ~39 requests per physician annually, and see roughly ...

Dry eye is a multifactorial disease characterized by a loss of homeostasis of the tear film layer, which can present itself in different ways. Dry Eye Awareness Month is dedicated ...

Justin Balko, PharmD, PhD, explains why residual disease in triple-negative breast cancer signals a biology gap, and what ADC trials and cell-free DNA monitoring may reveal. Patients with stage 2 and ...

As the number of actionable biomarkers in thoracic oncology continues to grow, the role of the multidisciplinary care team evolves to ensure patients receive comprehensive biomarker testing and ...

Workforce expansion authorized after the 2024 Harlem outbreak remains incomplete, with 35 staff onboard versus a planned 56, ...

Use of automated insulin delivery technology improves a Healthcare Effectiveness Data and Information Set quality measure in individuals with type 2 diabetes. Objective: To evaluate the effect of ...

Urs Weber, MD, discusses why comprehensive NGS is critical and where community biomarker testing often falls short.

Mean LDL-C at 6 months was 76.3 vs 85.6 mg/dL, yielding an adjusted difference of −6.62 mg/dL and higher attainment of LDL-C ...

Subcutaneous checkpoint inhibitors drove up volume and forced staffing changes, according to Angie Maynard, PharmD, MS, and bispecifics will bring another shift. The shift toward subcutaneous ...

CARDIO-TTRansform randomized 1432 wild-type or hereditary ATTR-CM patients to eplontersen 45 mg vs placebo every 4 weeks, with a primary composite endpoint assessed through week 140. Real-world ...

FDA approved zidesamtinib for previously treated ROS1+ locally advanced/metastatic NSCLC, marking GSK’s entry into approved lung cancer therapeutics following acquisition of Nuvalent’s portfolio. ROS1 ...

Deepak Bhatt, MD, MPH, MBA, discusses how new evidence, prevention definitions, and imaging advances are reshaping how PCSK9 ...